AVITA MEDICAL CDI 5:1 (AVH) Short Interest
AVITA MEDICAL CDI 5:1 (ASX:AVH) had 0.29% of shares reported as short positions as of 16 July 2026, representing 249,269 shares. AVITA MEDICAL CDI 5:1 operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Avita Medical Inc.
Avita Medical Inc. is a regenerative medicine company specializing in therapeutic skin restoration. Their flagship product, the RECELL System, is FDA-approved for treating thermal burn wounds and full-thickness skin defects. The company leverages patient-derived skin cells to enhance healing and accelerate recovery, positioning itself as a leader in acute wound care solutions.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4AVH intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Avita Medical Inc.
Latest AVH news
All newsAbout
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss AVH
Start a research thread or post the first pulse update